The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event – Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The ...

A study found that patients who took an mRNA vaccine along with immunotherapy for lung cancer or melanoma (a type of skin ...

Results of new research showing that COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients and prolonged ...

In the latest close session, Moderna (MRNA) was up +1.87% at $26.74. The stock outpaced the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 1.01%, while the tech-heavy Nasdaq ...

If mass vaccine deaths are imminent, it is not evident in the global life expectancy trends. Since the rollout of billions of ...

A new study suggests mRNA coronavirus vaccines effectively prolonged the lives of certain cancer patients. The study, ...

A COVID-19 mRNA vaccine may help advanced cancer patients live longer by boosting the immune response to immunotherapy.

UNLV scientists successfully introduced nanoparticles with messenger RNA into the pancreas for the first time with 99% ...

FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...